Markets:

Overview

News

Currencies

International

Treasuries

Twist Bioscience Corporation - Common Stock (NQ:TWST)

30.07 -1.94 (-6.06%)

Streaming Delayed Price Updated: 2:36 PM EST, Dec 1, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Twist Bioscience Corporation - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Twist Bioscience Inks Antibody Discovery Pact With MediSix Therapeutics ↗

April 07, 2022

Twist Bioscience Corporation (NASDAQ: TWST) and MediSix Therapeutics have collaborated to discover novel antibodies

Via Benzinga

Twist Bioscience Signs Antibody Discovery Collaboration with MediSix Therapeutics to Develop T-cell Therapies

April 07, 2022

From Twist Bioscience Corporation

Via Business Wire

DNA Data Storage Alliance Welcomes 50th Member

April 05, 2022

From DNA Data Storage Alliance

Via Business Wire

Twist Bioscience and Ginkgo Bioworks Sign New Collaboration

April 05, 2022

From Twist Bioscience Corporation

Via Business Wire

Know The 2 Healthcare Companies Cathie Wood's Ark Invest Bought On Friday ↗

April 02, 2022

Cathie Wood's Ark Invest may have had a disappointing 2021, but the fund's purchases/liquidations are always watched keenly by investors. On Friday, ETFs managed by...

Via Benzinga

Twist Bioscience Launches Synthetic RNA Positive Controls For SARS-CoV-2 Encapsulated Minicapsules ↗

March 21, 2022

Twist Bioscience Corporation (NASDAQ: TWST) has launched specific synthetic RNA positive controls for SARS-CoV-2 encapsulated in stainless steel mini capsules that...

Via Benzinga

Twist Bioscience Clocks ~50% Jump In Q1 Sales, Lifts FY22 Revenue Guidance ↗

February 04, 2022

Twist Bioscience Corp (NASDAQ: TWST) reported a

Via Benzinga

Recap: Twist Bioscience Q1 Earnings ↗

February 04, 2022

Twist Bioscience (NASDAQ:TWST) reported its Q1 earnings results on Friday, February 4, 2022 at 07:30 AM. Here's what investors need to know about the announcement.

Via Benzinga

Twist Bioscience Launches Synthetic RNA Positive Controls for SARS-CoV-2 Encapsulated in Imagene’s Stainless Steel Capsules

March 21, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Becomes Digital Preservation Coalition Supporter

February 28, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Present at Upcoming Virtual Conferences

February 28, 2022

From Twist Bioscience Corporation

Via Business Wire

Stocks That Hit 52-Week Lows On Tuesday ↗

March 08, 2022

Tuesday's session saw 729 companies set new 52-week lows. Areas of Interest About Today's 52-Week Lows: Amazon.com (NASDAQ:AMZN) was the largest firm on a...

Via Benzinga

Twist Bioscience Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

February 15, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Raises $250M Via Equity Issued At 11% Discount ↗

February 11, 2022

Twist Bioscience Corporation (NASDAQ: TWST) has priced its upsized underwritten public offering of 4.5 million at $55.00 per share, with gross proceeds of approximately...

Via Benzinga

Twist Bioscience Announces Pricing of an Upsized $250 Million Public Offering of Common Stock

February 10, 2022

From Twist Bioscience Corporation

Via Business Wire

The Daily Biotech Pulse: AstraZeneca Q4 Gets COVID Boost, Seagen Plunges On Earnings, Adcom Test Awaits Lilly ↗

February 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Twist Bioscience to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

February 10, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Announces Proposed Public Offering of Common Stock

February 09, 2022

From Twist Bioscience Corporation

Via Business Wire

C2i Genomics Partners with Twist Bioscience to Launch Reference Materials for Whole-Genome Cancer Detection

February 08, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience, Eleven Therapeutics Create Synthetic Viral RNA Molecules To Develop Antiviral Vaccines, Therapeutics ↗

February 07, 2022

Twist Bioscience Corp (NASDAQ: TWST) and Eleven Therapeutics have created a replicon tool that could be used for studying viral genome replication, antiviral drug...

Via Benzinga

Twist Bioscience and Eleven Therapeutics Create Replicon for Development of Antiviral Tools

February 07, 2022

From Twist Bioscience Corporation

Via Business Wire

The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures ↗

February 04, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

Twist Bioscience Reports First Quarter 2022 Financial Results

February 04, 2022

From Twist Bioscience Corporation

Via Business Wire

Earnings Scheduled For February 4, 2022 ↗

February 04, 2022

Companies Reporting Before The Bell • Brookfield Business (NYSE:BBU) is estimated to report earnings for its fourth quarter.

Via Benzinga

Earnings Outlook For Twist Bioscience ↗

February 03, 2022

Twist Bioscience (NASDAQ:TWST) is set to give its latest quarterly earnings report on Friday, 2022-02-04. Here's what investors need to know before the announcement. Analysts estimate that Twist...

Via Benzinga

Abcam Collaborates With Twist Bioscience to Enhance Antibody Discovery for Diagnostic and Research Applications

February 01, 2022

From Twist Bioscience Corporation

Via Business Wire

The Week Ahead In Biotech (Jan 31-Feb 5): Merck, Bristol-Myers Squibb, Lilly & Novartis Headline Large-Cap Biopharma Earnings News ↗

January 31, 2022

The broader market weakness pervaded into the biotech sector in the week ending Jan. 28, sending stocks lower.

Via Benzinga

Twist Bioscience Releases Inaugural ESG Report Highlighting Achievements and Initiatives in Diversity and Sustainability

January 31, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience Signs Collaboration with Artisan Bio to Engineer Next Generation Cell Therapeutics

January 25, 2022

From Twist Bioscience Corporation

Via Business Wire

Twist Bioscience to Report Fiscal 2022 First Quarter Financial Results on Friday, February 4, 2022

January 20, 2022

From Twist Bioscience Corporation

Via Business Wire

< Previous 1 2

...

10 11 12 13 14 15 16 17 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.